ETCare: A randomized, controlled, masked trial comparing two solutions for upper airway care in the NICU

Journal of Perinatology

Volumn 27, Issue 8, 2007, Pages 479-484

  Christensen, R D ^a   Rigby, G ^b   Schmutz, N ^a   Lambert, D K ^a   Wiedmeier, S E ^b,c   Burnett, J ^b   Scoffield, S H ^a   Muelleck, R ^b   Snow, K ^b   Woodhead, D D ^a   Snow, G L ^b  

^a McKay Dee Hospital Center   (United States)

^b LDS HOSPITAL   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN; SODIUM CHLORIDE;

ARTICLE; ARTIFICIAL VENTILATION; ASPIRATION; BLOOD CULTURE; CHRONIC LUNG DISEASE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOTRACHEAL TUBE; FEASIBILITY STUDY; FEMALE; HOSPITAL DISCHARGE; HOSPITAL INFECTION; HUMAN; INTUBATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEWBORN; NEWBORN INTENSIVE CARE; OXYGEN THERAPY; PHARMACIST; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; SEPSIS; SURVIVAL; UPPER RESPIRATORY TRACT;

CROSS INFECTION; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; INTENSIVE CARE, NEONATAL; INTUBATION, INTRATRACHEAL; PULMONARY SURFACTANTS; RESPIRATION, ARTIFICIAL; SODIUM CHLORIDE; SOLUTIONS; SUCTION;

EID: 34547513163     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/sj.jp.7211779     Document Type: Article

References (27)

1. Hagler DA, Traver GA. Endotracheal saline and suction catheters: Sources of lower airway contamination. Am J Crit Care 1994; 3: 444-447.
2. Trawoger P, Kolobow T, Cereda M, Giacomini M, Usuki J, Horiba K et al. Clearance of mucus from endotracheal tubes during intratracheal pulmonary ventilation. Anesthesiology 1997; 86: 1367-1374.
3. Kinloch D. Instillation of normal saline during endotracheal suctioning: effects on mixed venous oxygen saturation. Am J Crit Care 1999; 8: 231-240.
4. Lindgren S, Almgren B, Hogman M, Lethvall S, Houltz E, Lundin S et al. Effectiveness and side effects of closed and open suctioning: An experimental evaluation. Intens Care Med 2004; 30: 1630-1637.
5. Cunha-Goncalves D, Perez-de-Sa V, Ingimarsson J, Werner O, Larsson A. Inflation lung mechanics deteriorates markedly after saline instillation and open endotracheal suctioning in mechanically ventilated healthy piglets. Pediatr Pulmonol 2007; 42: 10-14.
6. Schulze A. Respiratory gas conditioning in infants with an artificial airway. Semin Neonatol 2002; 7: 369-377.
7. Zabner J, Sieler MP, Launspach JL, Karp PH, Kearney WR, Look DC et al. The osmolyte xylitol reduces the salt concentration of airway surface liquid and may enhance bacterial killing. Proc Natl Acad Sci USA 2000; 97: 11614-11619.
8. Zabner J, Smith JJ, Karp PH, Widdicombe JH, Welsh MJ. Loss of CFTR chloride channels alters salt absorption by cystic fibrosis airway epithelia in vitro. Mol Cell 1998; 2: 397-403.
9. Smith JJ, Travis SM, Greenberg EP, Welsh MJ. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 1996; 85: 229-236.
10. Singh PK, Tack BF, McCray PB, Welsh M. Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am J Physiol Lung Cell Mol Physiol 2000; 279: L799-1805.
11. Travis SM, Conway BA, Zaabner J, Smith JJ, Anderson NN, Singh PK et al. Activity of abundant antimicrobials of the human airway. Am J Respir Cell Mol Biol 1999; 20: 872-879.
12. Bals R. Epithelia antimicrobial peptides in host defense against infection. Current Sci Ltd Resp Res 2000; 1: 141-150.
13. Ganz T. Antimicrobial polypeptides in host defense of the respiratory tract. J Clin Invest 2002; 109: 693-697.
14. Bals R, Wilson JM. Cathelicidins - a family of multifunctional antimicrobial peptides. Cell Mol Life Sci 2003; 60: 711-720.
15. Wang Y, Walter G, Herting E, Agerberth B, Johansson J. Antibacterial activities of the cathelicidins prophenin (residues 62 to 79) and LL-37 in the presence of a lung surfactant preparation. Antimicrob Agents Chemother 2004; 48: 2097-2100.
16. Putsep K, Carlsson G, Boman HG, Anderson M. Deficiency of antibacterial peptides in patients with morbus Kostmann: An observational study. Lancet 2002; 360: 1144-1149.
17. Cirioni O, Giacometti A, Chiselli R, Bergnach C, Orlando F, Silvestri C et al. LL-37 protects rats against lethal sepsis caused by Gram-negative bacteria. Antimicrob Agents Chemother 2006; 50 1672-1679.
18. Woodhead DD, Lambert DK, Scoffield S, Snow G, Baer V, Christensen RD. Feasibility and preliminary safety study of a physiologically based solution for airway care in the neonatal intensive care unit. Neonatal Intensive Care 2006; 19: 29-33.
19. Jimenez-Reyes M, Sanchez-Aguirre FJ. Sodium and chlorine concentrations in mixed saliva of healthy and cystic fibrosis children. Appl Radiat Isot 1996; 47: 273-277.
20. Ben-Aryeh H, Lapid S, Szargel R, Benderly A, Gutman G. Composition of whole unstimulated saliva of human infants. Arch Oral Biol 1984; 29: 357-363.
21. Fanaroff AA, Korones SB, Wright LL, Verter J, Poland RI, Bauer CR et al. Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants. The National Institute of Child Health and Human Development Neonatal Research Network. Pediatr Infect Dis J 1998; 17: 593-598.
22. Devlin LA, Lassiter HA. Immunoenhancement to prevent nosocomial coagulase-negative staphylococcal sepsis in very low-birth-weight infants. Clin Perinatol 2004; 31: 69-75.
23. Kamagata-Kiyoura Y, Abe S, Yamaguchi H, Nitta T. Protective effects of human saliva on experimental murine oral candidiasis. J Infect Chemother 2004; 10: 253-255.
24. Borderon JC, Therizol-Ferly M, Saliba E, Laugier J, Quentin R. Prevention of Candida colonization prevents infection in a neonatal unit. Biol Neonate 2003; 84: 37-40.
25. Austin NC, Darlow B. Prophylactic oral antifungal agents to prevent systemic candida infection in preterm infants. Cochrane Database Syst Rev 2004 CD003478.
26. Hong IP, Lee SJ, Kim YS, Choi SG. Recombinant expression of human cathelicidin (hCAP18/LL-37) in Pichia pastoris. Biotechnol Lett 2007; 29: 73-78.
27. Moon JY, Henzler-Wildman KA, Ramamoorthy A. Expression and purification of a recombinant LL-37 from Escherichia coli. Biophys Acta 2006; 1758: 1351-1358.